SPECIAL REPORT

15 hospitals to be evaluated on insulin-pen safety

The initiative, developed by a committee of pharmacists who are experts in glycemic control and medication safety, will evaluate the hospitals' use of insulin pens and will recommend specific strategies to help promote the safe use of these devices.

"It is often challenging for healthcare providers to pinpoint the potential safety risks and implement process improvements."
—American Society of Health-System Pharmacists

Other Coverage

• Insulin pen problems persist in hospitals

• New once-weekly treatment for type 2 DM

• Afrezza, fast-acting, inhaled insulin, is approved

Editorial Questions? Contact the Editorial Team. Click Here.
Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.